ScholarIQanswers from OpenAlex

Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells

PaperCitations, authors & open-access status

Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells have?

ScholarIQcitation count

Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells has 372 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells published?

ScholarIQyear

Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells has 2004 year in the ScholarIQ index.

What is the open-access status of Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells?

ScholarIQoa status

Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells has closed oa status in the ScholarIQ index.

What is the DOI of Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells?

ScholarIQdoi

The DOI for Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells is on the source record.

What is the PMID of Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells?

ScholarIQpmid

The PMID for Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells is on the source record.

What is the OpenAlex record for Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells?

ScholarIQopenalex

The OpenAlex for Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial